Research programme: anti-FLT3 radioimmunoconjugates -Eli LillyAlternative Names: 177Lu-EB10; Flt-3 MAb
Latest Information Update: 07 Dec 2015
At a glance
- Originator ImClone Systems
- Developer Eli Lilly
- Class Immunoconjugates; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Haematological malignancies
Most Recent Events
- 28 Apr 2006 Preclinical trials in Haematological malignancies in USA (Parenteral)